Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases
S Komatsuzaki, M Zielonka, WK Mountford… - Genetics in …, 2019 - nature.com
Genetics in Medicine, 2019•nature.com
Purpose Krabbe disease (OMIM 245200) is an orphan neurometabolic disorder caused by a
deficiency of the lysosomal enzyme galactocerebrosidase (GALC). Hard clinical endpoints
and biomarker–phenotype correlations are useful for future clinical trials. Methods We
performed a quantitative analysis of published cases (N= 248) with Krabbe disease,
stratified by age at disease onset: early infantile (age 0–6 months), late infantile (age 7–36
months), juvenile/adolescent (age 37–180 months), and adult onset (> 180 months). Main …
deficiency of the lysosomal enzyme galactocerebrosidase (GALC). Hard clinical endpoints
and biomarker–phenotype correlations are useful for future clinical trials. Methods We
performed a quantitative analysis of published cases (N= 248) with Krabbe disease,
stratified by age at disease onset: early infantile (age 0–6 months), late infantile (age 7–36
months), juvenile/adolescent (age 37–180 months), and adult onset (> 180 months). Main …
Purpose
Krabbe disease (OMIM 245200) is an orphan neurometabolic disorder caused by a deficiency of the lysosomal enzyme galactocerebrosidase (GALC). Hard clinical endpoints and biomarker–phenotype correlations are useful for future clinical trials.
Methods
We performed a quantitative analysis of published cases (N = 248) with Krabbe disease, stratified by age at disease onset: early infantile (age 0–6 months), late infantile (age 7–36 months), juvenile/adolescent (age 37–180 months), and adult onset (>180 months). Main outcome measures were age of disease onset and survival. Cerebrospinal fluid (CSF) protein concentrations were explored as a potential predictor of survival. STROBE criteria were respected.
Results
Median age of onset was 4 months (early infantile), 14 months (late infantile), 48 months (juvenile), and 384 months (adult). Age of disease onset and therefore disease subtype determined survival rates. CSF protein concentrations predicted age at onset and survival rates in Krabbe disease. Patients with a CSF protein content ≤61.5 mg/dl survived significantly longer than patients with CSF protein values above this threshold.
Conclusion
We define the estimated survival in published Krabbe disease cases and demonstrate an association of CSF protein concentration with disease severity. These data inform patient care and clinical trials.
nature.com